Pharmaceuticals firm Roche Holding has agreed to buy the shares it doesn’t already own of Flatiron Health Inc., an oncology software company, for $1.9 billion, the companies said Thursday.
Pharmaceuticals firm Roche Holding has agreed to buy the shares it doesn’t already own of Flatiron Health Inc., an oncology software company, for $1.9 billion, the companies said Thursday.